Standout Papers

Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure 2023 2026 202474
  1. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure (2023)
    Robert J. Mentz, Jonathan H. Ward et al. Journal of the American College of Cardiology

Immediate Impact

10 standout
Sub-graph 1 of 4

Citing Papers

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
2024 Standout
Heart failure with preserved ejection fraction
2024 Standout
2 intermediate papers

Works of Jonathan H. Ward being referenced

Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
2023
Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan
2022

Author Peers

Author Last Decade Papers Cites
Jonathan H. Ward 268 53 24 61 28 284
Lina Benson 226 46 21 67 34 261
Willemien L. Verloop 248 29 47 50 16 284
David C. Humphrey 100 43 35 39 23 254
C. B. Granger 275 35 38 43 21 315
Uday Jadhav 198 48 74 64 32 278
Fu‐Chih Hsiao 174 50 60 59 40 263
Jan Wintrich 243 36 32 43 22 283
M Chaignon 164 58 77 28 34 299
Alberto Esteban‐Fernández 271 61 26 19 40 331
F. Zannad 231 83 34 25 15 308

All Works

Loading papers...

Rankless by CCL
2026